homecast

Homecast was founded in 2000 and listed on KOSDAQ in 2003, operating across electronic component distribution, digital set-top box (STB) manufacturing, and cosmetics production and sales.

More than 80% of total revenue is generated from electronic component distribution, supplying semiconductors used in smartphones, computers, automobiles, and home appliances to domestic and overseas customers.

The set-top box business develops satellite, terrestrial, and cable broadcast receivers under the HOMECAST brand, sold domestically and in overseas markets including India, China, Japan, the Middle East, Africa, Europe, and Oceania.

The cosmetics segment had operated multiple brands including 16 Brand, Wonderbath, and Cho Sung-ah Beauty, but in August 2025 the company divested most of its stake in cosmetics subsidiary CSA Cosmic under a control transfer agreement, substantially shrinking the consolidation scope and weight of this segment.

More recently, the company entered the aesthetic medical device market, launching the hyaluronic acid filler line 'LUCA CELLA' and skin booster line 'LUCA BLOSSOM.' It is also pursuing a new pharmaceutical and medical device distribution business as part of a mid-to-long-term diversification strategy.

Competitively, electronic component distribution is a low-margin field crowded with numerous small and mid-sized distributors, the set-top box market faces intensifying competition amid the spread of IPTV and OTT platforms, and the aesthetic device market sees the company entering as a late mover against established incumbents.

2025 consolidated revenue was KRW 97.996bn, nearly unchanged from KRW 97.870bn in 2024, but the operating loss widened to KRW 2.876bn (operating margin -2.9%) from KRW 2.438bn (-2.5%) in 2024.

Net income attributable to owners barely stayed positive at KRW 0.023bn, a sharp decline from KRW 0.880bn in 2024. 2023 was the weakest year of the four-year window, with revenue of KRW 63.698bn, an operating loss of KRW 10.192bn (margin -16.0%), and a net loss attributable to owners of KRW 9.943bn.

In 2022, revenue reached KRW 73.304bn with a positive operating profit of KRW 0.380bn (margin 0.5%), though the bottom line was already negative at KRW 0.726bn. In short, after the severe loss in 2023, revenue stabilized in 2024-2025, but the company has not achieved a clean turn to operating profitability.

Quarterly results show substantial volatility: revenue was KRW 15.467bn with an operating loss of KRW 1.284bn in Q3 2025, then surged to KRW 74.550bn in Q4 2025, delivering an operating profit of KRW 2.071bn and net income attributable to owners of KRW 4.321bn.

However, Q1 2026 revenue fell sharply to KRW 5.064bn with an operating loss of KRW 2.334bn and a net loss of KRW 0.469bn, and Q2 2026 revenue dropped further to KRW 0.867bn, with the operating loss widening to KRW 2.010bn and the net loss to KRW 2.356bn.

This pattern of sharp quarterly swings likely reflects both the lumpy revenue recognition typical of electronic component distribution and the change in consolidation scope following the 2025 divestment of the CSA Cosmic stake.

Indeed, non-controlling interests of KRW 16.020bn and KRW 11.781bn appeared on the balance sheet in 2023 and 2024 respectively but disappeared in 2025, corroborating the reduced consolidation scope.

Cumulative net income attributable to owners over the trailing four quarters (Q3 2025-Q2 2026) totaled KRW 2.507bn, a modest annualized profit, though the quarter-to-quarter variance is too wide to be viewed as a stable earnings base.

Meanwhile, operating cash flow deteriorated sharply to negative KRW 29.213bn in 2025 from positive KRW 17.252bn in 2024, even as the debt ratio actually declined to 5.8% in 2025 from 25.3% in 2024.

South Korea's electronic component distribution industry is being rapidly reshaped by global supply chain shifts and technological progress, with component demand trending upward on the back of IoT, 5G, and AI adoption.

However, the sector features numerous competing distributors, resulting in persistent margin pressure. The digital set-top box and broadcast equipment market is seeing intensifying competition as IPTV and OTT platforms proliferate.

The aesthetic medical device market for fillers and skin boosters has been growing rapidly in Korea, with skin boosters emerging as a new growth axis alongside the traditional botulinum toxin and filler segments.

This market features established leaders such as Pharmaresearch and Hugel, alongside major pharmaceutical companies including Daewoong Pharmaceutical preparing to enter, intensifying competitive dynamics.

Homecast enters this space as a late mover in terms of scale and brand recognition, and its revenue contribution from fillers and skin boosters has not yet been disclosed in verifiable figures.

With the cosmetics business shrinking following the CSA Cosmic divestment, the company's future growth trajectory is likely to hinge on the stabilization of the aesthetic device business and the core electronic component distribution operation.

The company declared its entry into the aesthetic medical device market in November 2025, unveiling the 'LUCA CELLA' filler and 'LUCA BLOSSOM' skin booster lineups, and around the same time participated in the InterCHARM Moscow Autumn 2025 exhibition in Russia to pursue overseas market access.

It is also pursuing a new pharmaceutical and medical device distribution business as part of continued diversification.

However, since the core electronic component distribution and set-top box businesses saw revenue surge in Q4 2025 followed by a sharp contraction in the first half of 2026, whether revenue normalizes again in the second half is a key point to watch.

No officially confirmed quantitative revenue targets or large-scale capacity expansion plans have been identified to date.

With the cosmetics business's consolidation scope reduced after the CSA Cosmic divestment, it will be important to monitor when the remaining new business, aesthetic medical devices, begins to make a meaningful contribution to revenue and profitability.

Disclosure flow related to the ownership structure of the largest shareholder and related parties also remains a variable that could affect the company's future business direction.